KYNTRA BIO, INC. (KYNB) › Shareholders' EquityKYNTRA BIO, INC. (KYNB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$46.25M2013: -$60.83M2014: $240.68M2015: $153.17M2016: $135.07M2017: $547.74M2018: $528.47M2019: $535.41M2020: $441.45M2021: $229.11M2022: -$1.48M2023: -$183.68M2024: -$205.12M2025: -$17.00M-$17.00M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$17.00M+91.7%2024-$205.12M-11.7%2023-$183.68M-12310.7%2022-$1.48M-100.6%2021$229.11M-48.1%2020$441.45M-17.5%2019$535.41M+1.3%2018$528.47M-3.5%2017$547.74M+305.5%2016$135.07M-11.8%2015$153.17M-36.4%2014$240.68M+495.6%2013-$60.83M-31.5%2012-$46.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share